购物车
- 全部删除
- 您的购物车当前为空
CCR4 antagonist 3-1 是一种具有较低活性的趋化因子受体 4 (CCR4) 拮抗剂,对 [125I]TARC (胸腺和活化调节趋化因子) 具有抑制作用,IC50 值为 1.7 μM。CCR4 antagonist 3-1 对放射标记的[125I]TARC和巨噬细胞来源的趋化因子(MDC) 与 CEM 细胞表面的CCR4 受体的结合有抑制作用, 并对 TARC 介导的 CEM 细胞的体外迁移有抑制作用,IC50 值为 6.4 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
CCR4 antagonist 3-1 是一种具有较低活性的趋化因子受体 4 (CCR4) 拮抗剂,对 [125I]TARC (胸腺和活化调节趋化因子) 具有抑制作用,IC50 值为 1.7 μM。CCR4 antagonist 3-1 对放射标记的[125I]TARC和巨噬细胞来源的趋化因子(MDC) 与 CEM 细胞表面的CCR4 受体的结合有抑制作用, 并对 TARC 介导的 CEM 细胞的体外迁移有抑制作用,IC50 值为 6.4 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 928 | 现货 | |
5 mg | ¥ 2,320 | 现货 | |
10 mg | ¥ 3,730 | 现货 | |
25 mg | ¥ 5,930 | 现货 | |
50 mg | ¥ 7,850 | 现货 | |
100 mg | ¥ 10,800 | 现货 | |
200 mg | ¥ 14,500 | 现货 |
产品描述 | CCR4 antagonist 3-1 is a less active chemokine receptor 4 (CCR4) antagonist that inhibits [125I]TARC (thymus and activation-regulated chemokine) with an IC50 value of 1.7 μM. CCR4 antagonist 3-1 inhibits the binding of radiolabeled [125I]TARC and macrophage-derived chemokine ( MDC) to CEM cell surface and inhibits TARC-mediated CEM cell migration in vitro with an IC50 value of 6.4 μM. CCR4 antagonist 3 inhibited the binding of radiolabeled [125I]TARC and macrophage-derived chemokine (MDC) to the CCR4 receptor on the surface of CEM cells and inhibited TARC-mediated migration of CEM cells in vitro with an IC50 value of 6.4 μM. |
体内活性 | CCR4 antagonist 3-1 以0.5 mg/kg静脉注射(i.v.)和2 mg/kg口服(p.o.)的单次剂量,展现了4.2 L/h/kg的高清除率,0.4小时的短半衰期以及2%的口服生物利用度。[1] |
分子量 | 240.32 |
分子式 | C14H12N2S |
CAS No. | 1957-01-3 |
Smiles | N(C=1C2=C(C=CC1)C=CC=C2)C3=NC(C)=CS3 |
存储 | store at low temperature | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (187.25 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容